New Survey Finds Enhanced Pain Management for Blood Draw and IV Insertions in Children Would Benefit Patients, Families and Nursing Staff
-More than 2,000 Nurses from Preeminent Organizations Report Job Satisfaction Would Be Improved by Better Pain Management Practices-
Posted on Thu, May. 08, 2008
By Anesiva, Inc.
TAMPA, Fla., May 8 --
According to a new survey of
nurses to be presented tomorrow at the 27th annual meeting of the American
Pain Society (APS), increasing the use of non-pharmacologic interventions
(such as distraction techniques, parental coaching, and comfort positions) and
pharmacologic options that do not cause treatment delays or vasoconstriction
would enhance patient and staff satisfaction.(1) The survey, sponsored by
Anesiva, Inc. (Nasdaq: ANSV) also found that 91 percent of respondents agree
that better pain management for IV insertions and blood draws (peripheral
venous access procedures) in children improves their job performance and 81
percent agree that it improves their job satisfaction.(1)
More than 18 million peripheral venous access procedures, including blood
draws and IV insertions, are performed on children in U.S. hospitals each
year.(2) A study published in the journal Pediatric Nursing shows that these
types of peripheral venous access procedures are among the most frequently
reported painful events in hospitalized children.(3) The American Pain
Society and the American Academy of Pediatrics, among other organizations,
have developed recommendations that emphasize the importance of minimizing
procedural pain in children whenever possible.(4) However, despite the
existence of these recommendations, children undergoing these procedures
remain largely under-treated.(5) This is partly due to the fact that many
currently available local anesthetics take 20 minutes or longer to become
effective, making their use in today's fast-paced hospital environment
difficult.
"As a pediatric anesthesiology research nurse, I regularly witness
children's pain caused by blood draws and IV insertions," said survey author
Terri Voepel-Lewis, MSN, RN, C.S. Mott Children's Hospital. "This survey
reinforces the enormous positive impact nurses can have on a patient's
experience, simply by using pharmacologic and other management options
available to manage peripheral venous access pain."
Data were collected by an on-line survey administered to a national sample
of nurse participants. The survey was distributed via e-mailed invitation to
the membership of the Emergency Nurses Association, the Infusion Nurses
Society, and the Society of Pediatric Nurses. Participants were asked to rate
the importance of managing blood draw and IV pain, the impact that these
procedures have on patient and nurse satisfaction, and their attitudes on the
value of available pharmacologic and non-pharmacologic interventions. A total
of 2,187 nurses completed the survey.(1)
Nearly all (96 percent) participants agree that inserting an IV line into
a fearful, anxious child can be challenging -- a situation that is encountered
76 percent of the time.(1) As reported by survey respondents, children
receiving an IV insertion need to be restrained about 74 percent of the
time.(1) In addition, the survey found that children who do not receive a
topical local anesthetic (TLA) prior to blood draws and IV insertions
experience distress and anxiety 72 percent of the time.(1) Nearly all survey
participants (92 percent) agreed that patients and their families would
benefit from the use of a fast-acting TLA for such procedures.(1)
Most surveyed nurses (96 percent) reported using non-pharmacologic options
to manage children's pain. Despite the fact that 66 percent of respondents
reported having experience using pharmacologic interventions, they indicated
that TLAs are employed less than a third (28 percent) of the time. Primary
reasons cited for not using pharmacologic interventions include their
association with slow onset of action, treatment delays, and vasoconstriction,
as well as lack of physician authorization.(1)
"This survey reinforces a core belief of the children's pain
community -- that all children deserve to be offered appropriate medical
resources and comfort for peripheral venous access procedures," said
William T. Zempsky, M.D., associate professor, Department of Pediatrics,
University of Connecticut; associate director, Pain Relief Program,
Connecticut Children's Medical Center, Hartford. "Healthcare providers should
consider the use of pharmacologic treatments and non-pharmacologic techniques
to reduce the unnecessary suffering associated with these procedures."
About Anesiva and its Diverse Pipeline of Pain Products
Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be
the leader in the development and commercialization of novel pharmaceutical
products for pain management. The company has one FDA-approved product,
Zingo(TM), for the reduction of pain associated with peripheral venous access
procedures in children ages three to 18. The second product in Anesiva's
pipeline, Adlea(TM), has been shown to reduce pain after only a single
administration for weeks to months in multiple settings in numerous mid-stage
clinical trials for site-specific, acute and chronic, moderate-to-severe pain.
Anesiva is based in South San Francisco, CA. For more information about
Anesiva's leadership in the development of products for pain management, and
an overview of the clinical challenges being addressed by its product
candidates, go to http://www.anesiva.com.
(1) Papa AM, Morgan R, Zempsky WT et al. Nurse and Patient Satisfaction
Negatively Impacted by Inadequate Peripheral Venous Access Pain
Management in Children. To be presented by Papa et al. at: American
Pain Society; May 8-10, 2008; Tampa, Florida. (2) Anesiva, Data on File.
(3) Wong DL, Baker CM. Pain in children: comparison of assessment scales.
Pediatr Nurs. 1988;14(1):9-17.
(4) American Academy of Pediatrics Committee on Psychosocial Aspects of
Child and Family Health and American Pain Society Task Force on Pain
in Infants, Children, and Adolescents. The assessment and management
of acute pain in infants, children, and adolescents. Pediatrics.
2001;108:793-797.
(5) MacLean S, Obispo J, Young KD. The gap between pediatric emergency
department procedural pain management treatments available and actual
practice. Pediatr Emerg Care. 2007;23(2):87-93.
SOURCE Anesiva, Inc.
Carol DeGuzman, Investor Relations of Anesiva, Inc., +1-650-246-6898, deguzman@anesiva.com; or Melissa Lang, Media Relations of WeissComm Partners, +1-212-301-7208, mlang@wcpglobal.com, for Anesiva, Inc.,
Join the discussion
The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from personal comments and remarks that are off point. In order to post comments, you must be a registered user of MiamiHerald.com. Your username will show along with the comments you post. Not a registered user? It's Free!
Register here. Thank you for taking the time to offer your thoughts.